Gurmit Singh, McMaster University
Juravinski Cancer Centre
Pathology & Molecular Medicine
Professor
Hamilton, Ontario
gurmit.singh@hrcc.on.ca
Office:
(905) 387-9711 ext. 67102
(905) 387-9711 ext. 67500
Expert In
Bio/Research
Gurmit Singh has been the Director of Research at the Juravinski Cancer Centre (JCC) since 1994. The JCC is one of eight Regional Cancer Centres of Cancer Care Ontario, recognized nationally and internationally for its leading edge research to detect and eradicate cancer. Singh is also a Professo...
Click to Expand >>
Click to Expand >>
Bio/Research
Gurmit Singh has been the Director of Research at the Juravinski Cancer Centre (JCC) since 1994. The JCC is one of eight Regional Cancer Centres of Cancer Care Ontario, recognized nationally and internationally for its leading edge research to detect and eradicate cancer. Singh is also a Professor in the Department of Pathology and Molecular Medicine and an Associate Member in the Departments of Biochemistry and Biology at McMaster University.
Professor Singh received his PhD in Pharmacology from Dalhousie University and earned a Post Doctoral Fellowship from the University of Florida. His general areas of research interest include prostate and breast cancer research, more specifically: control of cancer mestasis to bone; redox signaling via mitochondria in breast and prostate cancer; and the role of photodynamic therapy in prostate cancer.
The author of more than 100 peer reviewed publications, Singh’s research, and that of his research team, has attracted over $10 million in funding from various provincial, federal and U.S. health and cancer research agencies.
Professor Singh held the Ontario Cancer Treatment and Research Foundation Career Scientist Award from 1984-1996, and since 1996, has been honored by the Senior Scientist Award from Cancer Care Ontario.
Click to Shrink <<
Professor Singh received his PhD in Pharmacology from Dalhousie University and earned a Post Doctoral Fellowship from the University of Florida. His general areas of research interest include prostate and breast cancer research, more specifically: control of cancer mestasis to bone; redox signaling via mitochondria in breast and prostate cancer; and the role of photodynamic therapy in prostate cancer.
The author of more than 100 peer reviewed publications, Singh’s research, and that of his research team, has attracted over $10 million in funding from various provincial, federal and U.S. health and cancer research agencies.
Professor Singh held the Ontario Cancer Treatment and Research Foundation Career Scientist Award from 1984-1996, and since 1996, has been honored by the Senior Scientist Award from Cancer Care Ontario.
Click to Shrink <<